ANGIODYNAMICS INC — Director's Dealing 2024

Aug 2, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2024-07-17

Reporting Person: Nighan Warren JR (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-07-17	Common Stock	M	5677	—	Acquired	46675	Direct
2024-07-17	Common Stock	F	1666	$7.4	Disposed	45009	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-07-17	Performance Right	$	M	7550	Acquired		Common Stock (7550)	Direct

Footnotes

F1: This acquisition of 5,677 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 21, 2021.

F2: The exempt disposition of 1,666 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 21, 2021.

F3: On July 21, 2021, the reporting person received a target grant of 7,550 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 5,677 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited.